Ileal Bile Acid Transporter Inhibitor [EPC]

Ileal Bile Acid Transporter Inhibitor [EPC] was reported 455 times

These side effects are most commonly reported by patients taking drugs of the Ileal Bile Acid Transporter Inhibitor [EPC] class:

# Drug class Count
0 DIARRHOEA 113
1 PRURITUS 109
2 OFF LABEL USE 104
3 DRUG INEFFECTIVE 48
4 LIVER TRANSPLANT 36
5 ABDOMINAL PAIN UPPER 31
6 PRODUCT DOSE OMISSION ISSUE 30
7 HEPATIC ENZYME INCREASED 25
8 ABDOMINAL PAIN 23
9 BLOOD BILIRUBIN INCREASED 22
10 VOMITING 22
11 ALANINE AMINOTRANSFERASE INCREASED 20
12 BILE ACIDS INCREASED 20
13 NAUSEA 20
14 ASPARTATE AMINOTRANSFERASE INCREASED 15
15 JAUNDICE 15
16 TRANSAMINASES INCREASED 14
17 ABDOMINAL DISCOMFORT 11
18 DRUG INTERACTION 11
19 WEIGHT DECREASED 11
20 PRODUCT USE ISSUE 10
21 CONSTIPATION 9
22 FATIGUE 9
23 DEATH 8
24 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8
25 HEADACHE 8
26 HYPOVITAMINOSIS 8
27 INFLUENZA 8
28 TREATMENT NONCOMPLIANCE 8
29 DEHYDRATION 7
30 DISEASE PROGRESSION 7
31 HEPATIC CIRRHOSIS 7
32 INSOMNIA 7
33 LIVER FUNCTION TEST INCREASED 7
34 PYREXIA 7
35 WEIGHT INCREASED 7
36 BILIRUBIN CONJUGATED INCREASED 6
37 BLOOD ALKALINE PHOSPHATASE INCREASED 6
38 ILLNESS 6
39 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6
40 INTERNATIONAL NORMALISED RATIO INCREASED 6
41 DECREASED APPETITE 5
42 DRUG INTOLERANCE 5
43 HEPATIC FAILURE 5
44 HEPATIC FUNCTION ABNORMAL 5
45 HOSPITALISATION 5
46 INCORRECT DOSE ADMINISTERED 5
47 INTENTIONAL PRODUCT MISUSE 5
48 LIVER FUNCTION TEST ABNORMAL 5
49 SEPSIS 5
50 THERAPEUTIC RESPONSE UNEXPECTED 5
51 WEIGHT GAIN POOR 5
52 ABDOMINAL DISTENSION 4
53 ALOPECIA 4
54 ANAEMIA 4
55 CHOLESTASIS 4
56 FLATULENCE 4
57 GASTROINTESTINAL DISORDER 4
58 GASTROOESOPHAGEAL REFLUX DISEASE 4
59 HEPATOMEGALY 4
60 HEPATOTOXICITY 4
61 MALAISE 4
62 PANCREATITIS 4
63 PRODUCT DOSE OMISSION IN ERROR 4
64 SCRATCH 4
65 SPLENOMEGALY 4
66 THERAPY NON-RESPONDER 4
67 VIRAL INFECTION 4
68 ASTHENIA 3
69 BLOOD SODIUM DECREASED 3
70 CHOLELITHIASIS 3
71 COAGULOPATHY 3
72 COLITIS 3
73 CONDITION AGGRAVATED 3
74 COUGH 3
75 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3
76 DRY SKIN 3
77 EPISTAXIS 3
78 FAECES DISCOLOURED 3
79 FAECES SOFT 3
80 GASTROINTESTINAL HAEMORRHAGE 3
81 GASTROINTESTINAL PAIN 3
82 HAEMORRHAGE 3
83 HEPATIC STEATOSIS 3
84 HEPATOCELLULAR CARCINOMA 3
85 INTENTIONAL PRODUCT USE ISSUE 3
86 INTENTIONAL UNDERDOSE 3
87 IRRITABILITY 3
88 LABORATORY TEST ABNORMAL 3
89 LIVER DISORDER 3
90 MUSCLE SPASMS 3
91 PAIN 3
92 PNEUMONIA 3
93 POLLAKIURIA 3
94 POOR QUALITY SLEEP 3
95 PRODUCT RESIDUE PRESENT 3
96 SINUSITIS 3
97 SLEEP DISORDER 3
98 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
99 UNDERDOSE 3
100 ACUTE KIDNEY INJURY 2
101 ACUTE RESPIRATORY FAILURE 2
102 AGITATION 2
103 ANXIETY 2
104 ARTHRALGIA 2
105 ASCITES 2
106 BLOOD BILIRUBIN ABNORMAL 2
107 BLOOD POTASSIUM DECREASED 2
108 CARDIAC DISORDER 2
109 CHOLANGITIS 2
110 CONTUSION 2
111 DECREASED ACTIVITY 2
112 DEFAECATION URGENCY 2
113 DIPLOPIA 2
114 DIZZINESS 2
115 DYSPEPSIA 2
116 EXPOSURE DURING PREGNANCY 2
117 FEEDING DISORDER 2
118 FEELING ABNORMAL 2
119 FEELING HOT 2
120 GAMMA-GLUTAMYLTRANSFERASE DECREASED 2
121 GASTROENTERITIS 2
122 GASTROENTERITIS ASTROVIRAL 2
123 HAEMATOCHEZIA 2
124 HEAVY MENSTRUAL BLEEDING 2
125 HEPATIC CANCER 2
126 HEPATIC ENZYME ABNORMAL 2
127 HEPATITIS 2
128 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2
129 IRRITABLE BOWEL SYNDROME 2
130 MALNUTRITION 2
131 MUCOUS STOOLS 2
132 OCULAR ICTERUS 2
133 OROPHARYNGEAL PAIN 2
134 PERIPHERAL SWELLING 2
135 PORTAL HYPERTENSION 2
136 PRODUCT SUPPLY ISSUE 2
137 PRODUCT USE COMPLAINT 2
138 PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 2
139 SKIN ABRASION 2
140 SOCIAL AVOIDANT BEHAVIOUR 2
141 SOMNOLENCE 2
142 TESTICULAR PAIN 2
143 THERAPEUTIC PRODUCT EFFECT DECREASED 2
144 THERAPEUTIC RESPONSE DECREASED 2
145 THERAPEUTIC RESPONSE SHORTENED 2
146 URTICARIA 2
147 VITAMIN D DECREASED 2
148 VOMITING PROJECTILE 2
149 ABDOMINAL PAIN LOWER 1
150 ACCIDENTAL UNDERDOSE 1
151 ACIDOSIS 1
152 ACUTE SINUSITIS 1
153 ADENOVIRAL UPPER RESPIRATORY INFECTION 1
154 ADJUSTMENT DISORDER 1
155 ADVERSE DRUG REACTION 1
156 ADVERSE EVENT 1
157 AGEUSIA 1
158 ALPHA 1 FOETOPROTEIN INCREASED 1
159 ANAL INCONTINENCE 1
160 ANAL INJURY 1
161 ANAL PRURITUS 1
162 AORTIC VALVE STENOSIS 1
163 APPENDICECTOMY 1
164 APPENDICITIS 1
165 AST/ALT RATIO ABNORMAL 1
166 ASTHMA 1
167 ATRIAL FIBRILLATION 1
168 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1
169 AUTOIMMUNE HEPATITIS 1
170 BACK PAIN 1
171 BILE ACID MALABSORPTION 1
172 BILE ACIDS ABNORMAL 1
173 BILE DUCT STONE 1
174 BILIARY COLIC 1
175 BLINDNESS 1
176 BLISTER 1
177 BLOOD BILIRUBIN DECREASED 1
178 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1
179 BLOOD FIBRINOGEN INCREASED 1
180 BLOOD GLUCOSE DECREASED 1
181 BLOOD GLUCOSE INCREASED 1
182 BLOOD LACTIC ACID INCREASED 1
183 BLOOD PRESSURE INCREASED 1
184 BLOOD SODIUM INCREASED 1
185 BLOOD TEST ABNORMAL 1
186 BONE PAIN 1
187 BOWEL MOVEMENT IRREGULARITY 1
188 C-REACTIVE PROTEIN INCREASED 1
189 CARBON DIOXIDE DECREASED 1
190 CEREBROVASCULAR ACCIDENT 1
191 CHOLANGITIS SCLEROSING 1
192 CHOLESTASIS OF PREGNANCY 1
193 CHOLESTATIC PRURITUS 1
194 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
195 COAGULATION TIME ABNORMAL 1
196 COLD SWEAT 1
197 COLOUR BLINDNESS 1
198 CONFUSIONAL STATE 1
199 COVID-19 1
200 CROUP INFECTIOUS 1
201 CRYING 1
202 DEAFNESS 1
203 DEPRESSED MOOD 1
204 DEPRESSION 1
205 DEVELOPMENTAL DELAY 1
206 DIABETIC FOOT INFECTION 1
207 DISEASE COMPLICATION 1
208 DIZZINESS POSTURAL 1
209 DRUG EFFECT LESS THAN EXPECTED 1
210 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
211 DRUG LEVEL INCREASED 1
212 DRUG-INDUCED LIVER INJURY 1
213 DRY EYE 1
214 DRY MOUTH 1
215 DRY THROAT 1
216 DYSENTERY 1
217 EAR HAEMORRHAGE 1
218 EAR INFECTION 1
219 EAR PAIN 1
220 EATING DISORDER 1
221 ENTERAL NUTRITION 1
222 ENTEROVIRUS INFECTION 1
223 EPILEPSY 1
224 EXTRA-AXIAL HAEMORRHAGE 1
225 FAECES PALE 1
226 FALL 1
227 FLUID INTAKE REDUCED 1
228 FOETAL HYPOKINESIA 1
229 FREQUENT BOWEL MOVEMENTS 1
230 FUNGAL INFECTION 1
231 GAIT DISTURBANCE 1
232 GASTROENTERITIS VIRAL 1
233 GASTROINTESTINAL INFECTION 1
234 GASTROINTESTINAL VIRAL INFECTION 1
235 GENERAL PHYSICAL HEALTH DETERIORATION 1
236 GONORRHOEA 1
237 GROWTH RETARDATION 1
238 HAEMATEMESIS 1
239 HAEMATURIA 1
240 HAEMOGLOBIN DECREASED 1
241 HEART RATE INCREASED 1
242 HELICOBACTER INFECTION 1
243 HEPATIC CANCER RECURRENT 1
244 HEPATIC ENCEPHALOPATHY 1
245 HEPATIC FIBROSIS 1
246 HEPATIC PAIN 1
247 HEPATOSPLENOMEGALY 1
248 HERNIA 1
249 HYPERCHLORAEMIA 1
250 HYPERCHLORHYDRIA 1
251 HYPERSENSITIVITY 1
252 HYPERSPLENISM 1
253 HYPOAESTHESIA 1
254 HYPOGLYCAEMIA 1
255 HYPONATRAEMIC SEIZURE 1
256 HYPOTHYROIDISM 1
257 ILEAL ULCER 1
258 ILL-DEFINED DISORDER 1
259 IMPAIRED WORK ABILITY 1
260 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1
261 INCONTINENCE 1
262 INCORRECT DOSAGE ADMINISTERED 1
263 INCREASED APPETITE 1
264 INCREASED INSULIN REQUIREMENT 1
265 INFECTION 1
266 INSURANCE ISSUE 1
267 INTENTIONAL DOSE OMISSION 1
268 INTUSSUSCEPTION 1
269 INVESTIGATION ABNORMAL 1
270 IRON DEFICIENCY 1
271 KNEE OPERATION 1
272 LEUKODYSTROPHY 1
273 LIVER INJURY 1
274 LIVER OPERATION 1
275 LOSS OF CONSCIOUSNESS 1
276 LUNG INFILTRATION 1
277 LYMPHOMA 1
278 MACULOPATHY 1
279 MALABSORPTION 1
280 MEDICATION ERROR 1
281 MELAENA 1
282 MENTAL IMPAIRMENT 1
283 METAPLASIA 1
284 METASTASES TO LUNG 1
285 MIDDLE EAR EFFUSION 1
286 MIDDLE INSOMNIA 1
287 MITRAL VALVE INCOMPETENCE 1
288 MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED 1
289 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1
290 MUSCLE TWITCHING 1
291 MUSCULOSKELETAL PAIN 1
292 NASAL CONGESTION 1
293 NEUROLOGICAL SYMPTOM 1
294 OBSTRUCTION GASTRIC 1
295 OEDEMA 1
296 OEDEMA PERIPHERAL 1
297 ORAL CANDIDIASIS 1
298 OVERFLOW DIARRHOEA 1
299 PARAESTHESIA 1
300 PARAESTHESIA ORAL 1
301 PERICARDIAL EFFUSION 1
302 PERIORBITAL SWELLING 1
303 PHARYNGITIS 1
304 PLEURAL EFFUSION 1
305 POOR SCHOOL ATTENDANCE 1
306 PORTAL HYPERTENSIVE GASTROPATHY 1
307 POST PROCEDURAL DIARRHOEA 1
308 POST PROCEDURAL INFLAMMATION 1
309 POTENTIATING DRUG INTERACTION 1
310 PRE-EXISTING CONDITION IMPROVED 1
311 PRIMARY BILIARY CHOLANGITIS 1
312 PROCEDURAL COMPLICATION 1
313 PRODUCT ADMINISTRATION ERROR 1
314 PRODUCT DISPENSING ERROR 1
315 PRODUCT DOSAGE FORM ISSUE 1
316 PRODUCT INEFFECTIVE 1
317 PRODUCT INFORMATION CONTENT COMPLAINT 1
318 PRODUCT LABEL CONFUSION 1
319 PRODUCT PACKAGING ISSUE 1
320 PRODUCT PREPARATION ISSUE 1
321 PRODUCT STORAGE ERROR 1
322 PRODUCT STORAGE ISSUE 1
323 PRODUCT TASTE ABNORMAL 1
324 PRODUCT USE IN UNAPPROVED INDICATION 1
325 PROTEIN TOTAL DECREASED 1
326 RECTAL HAEMORRHAGE 1
327 RENAL CYST 1
328 RENAL IMPAIRMENT 1
329 RENAL INJURY 1
330 RENAL TRANSPLANT 1
331 RESPIRATORY TRACT INFECTION 1
332 RESPIRATORY TRACT INFECTION VIRAL 1
333 RETCHING 1
334 RHINORRHOEA 1
335 RHINOVIRUS INFECTION 1
336 SCAB 1
337 SCAR 1
338 SCLERAL DISCOLOURATION 1
339 SEPTIC SHOCK 1
340 SKIN BURNING SENSATION 1
341 SKIN DISORDER 1
342 SKIN LACERATION 1
343 SKIN LESION 1
344 SKIN ODOUR ABNORMAL 1
345 SLEEP TERROR 1
346 STAPHYLOCOCCAL BACTERAEMIA 1
347 STAPHYLOCOCCAL IMPETIGO 1
348 STOMA CLOSURE 1
349 STOMA SITE DISCOMFORT 1
350 STRESS AT WORK 1
351 SUBDURAL HAEMORRHAGE 1
352 SUICIDAL IDEATION 1
353 SUSPECTED DRUG-INDUCED LIVER INJURY 1
354 SYMPTOM RECURRENCE 1
355 TENDONITIS 1
356 TERMINAL STATE 1
357 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 1
358 THERAPEUTIC RESPONSE DELAYED 1
359 THERAPY CHANGE 1
360 THROMBOCYTOPENIA 1
361 TOOTH EXTRACTION 1
362 TOOTH INFECTION 1
363 TOTAL BILE ACIDS INCREASED 1
364 TRANSAMINASES ABNORMAL 1
365 TRANSFUSION 1
366 TRANSPLANT REJECTION 1
367 TREMOR 1
368 TRICUSPID VALVE INCOMPETENCE 1
369 TYMPANIC MEMBRANE PERFORATION 1
370 UNDERWEIGHT 1
371 UNEVALUABLE EVENT 1
372 UPPER RESPIRATORY TRACT INFECTION 1
373 URINARY TRACT INFECTION 1
374 VARICES OESOPHAGEAL 1
375 VISION BLURRED 1
376 VISUAL IMPAIRMENT 1
377 VITAMIN K DECREASED 1
378 VITAMIN K DEFICIENCY 1
379 WITHDRAWAL HYPERTENSION 1
380 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1
381 YELLOW SKIN 1